The outcomes of adult patients with haematological malignancy requiring admission to the intensive care unit

Journal of the Intensive Care Society

Volumn 12, Issue 2, 2011, Pages 112-125

  McDowall, K L ^a   Hart, A J ^b   Cadamy, A J ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Critical care; Haematological malignancy; Neoplasms; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LEUKOCYTE ANTIGEN; SODIUM; UREA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE RESPIRATORY FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; BLOOD OXYGEN TENSION; BONE MARROW TRANSPLANTATION; BREATHING RATE; CANCER SURVIVAL; COCHRANE LIBRARY; DISEASE SEVERITY; EMBASE; FOLLOW UP; GLASGOW COMA SCALE; GRAFT VERSUS HOST REACTION; HEART RATE; HEMATOCRIT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; HYPERBILIRUBINEMIA; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVER DYSFUNCTION; LIVER FAILURE; MEDLINE; MULTICENTER STUDY (TOPIC); MYELOABLATIVE CONDITIONING; MYELOMA; NEUTROPENIA; OUTCOME ASSESSMENT; PATIENT SELECTION; RECEIVER OPERATING CHARACTERISTIC; RESUSCITATION; RETROSPECTIVE STUDY; REVIEW; SODIUM BLOOD LEVEL; SYSTEMATIC REVIEW (TOPIC); SYSTOLIC BLOOD PRESSURE; THROMBOCYTOPENIA; UREA BLOOD LEVEL; URINE VOLUME;

EID: 79958123283     PISSN: 17511437     EISSN: None     Source Type: Journal    
DOI: 10.1177/175114371101200207     Document Type: Review

References (77)

1. Gordon AC, Oakervee HE, Kaya B et al. Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: A prospective observational study of ward and intensive careunit based care. Anaesthesia 2005;60:340-47.
2. Pawson H, Jayaweera A, Wigmore T. Intensive care management of patients following haematopoietic stem cell transplantation. Curr Anaesth Crit Care 2008;19:80-90.
3. Silfvast T, Pettila V, Ihalainen A, Elonen E. Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand 2003;47:301-06.
4. Peigne V, Rusinova K, Karlin L et al. Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 2009;35: 512-18.
5. Hill QA. Intensify, resuscitate or palliate: Decision making in the critically ill patient with haematological malignancy. Blood Rev 2010;24:17-25.
6. fessa B, Tefferi A, Dunn WF et al. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 2003;31: 1715-21.
7. Barnes RA, Stallard N. Severe infections after bone marrow transplantation. Curr Opin Crit Care 2001;7:362-66.
8. Wells G, Shea B, O'Connell D, Peterson et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. 2008; Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed 01/08, 2010.
9. Altman D. Systematic reviews of evaluations of prognostic variables. In: Egger M, Smith G, Altman D, eds. Systematic Reviews in Healthcare, BMJ Books; 2001:p228-246.
10. von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61: 344-349.
11. Afessa B, Tefferi A, Hoagland HC et al. Outcome of recipients of bone marrow transplants who require intensive care unit support. Mayo Clin Proc 1992;67:117-22.
12. Bach PB, Schrag D, Nierman DM et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001;98:3234-240.
13. Naeem N, Reed MD, Creger RJ et al. Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: Does it really matter? Bone Marrow Transplant 2006;37:119-33.
14. Azoulay E, Alberti C, Bornstain C et al. Improved survival in cancer patients requiring mechanical ventilatory support: Impact of non-invasive mechanical ventilatory support. Crit Care Med 2001;29:519-525.
15. Azoulay E, Recher C, Alberti C et al. Changing use of intensive care for hematological patients: The example of multiple myeloma. Intensive Care Med 1999;25:1395-401.
16. Azoulay E, Thiery G, Chevret S et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine 2004;83:360-370.
17. BaHammam AS, Basha SJ, Masood MI, Shaik SA. Outcome of patients with hematological malignancies admitted to the intensive care unit with life-threatening complications. Saudi Med J 2005;26:246-50.
18. Benoit DD, Depuydt PO, Peleman RA et al. Documented and clinically suspected bacterial infection precipitating intensive care unit admission inpatients with hematological malignancies: Impact on outcome. Intensive Care Med 2005;31:934-42.
19. Benoit DD, Vandewoude KH, Decruyenaere JM et al. Outcome and earlyprognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit CareMed 2003;31:104-12.
20. Benoit DD, Hoste EA, Depuydt PO et al. Outcome in critically illmedical patients treated with renal replacement therapy for acute renal failure: Comparison between patients with and those without haematological malignancies. Nephrol Dialysis Transpl 2005;20:552-58.
21. Berghmans T, Meert AP, Markiewicz E, Sculier JP. Continuous venovenous haemofiltration in cancer patients with renal failure: A singlecentre experience. Support Care Cancer 2004;12:306-11.
22. Bruennler T, Mandraka F, Zierhut S et al. Outcome of hemato-oncologic patients with and without stem cell transplantation in a medical ICU. Eur J Med Res 2007;12:323-30.
23. Cherif H, Martling C, Hansen J et al. Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication. Support Care Cancer 2007;15:1393-98.
24. Cornet AD, Issa AI, van de Loosdrecht AA et al. Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 2005;74:511-16.
25. Cubitt J, Smythe J, O'Gara G, Farquhar-Smith WP. Examination of risk factors for mortality of patients with haematological malignancies admitted to intensive care. Eur J Cancer Suppl 2007;5:351-51.
26. Depuydt PO, Benoit DD, Vandewoude KH et al. Outcome innoninvasively and invasively ventilated hematologic patients with acute respiratory failure. Chest 2004;126:1299-306.
27. Ferrà C, Marcos P, Misis M et al. Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: A single-center experience. Int J Hematol 2007;85:195-202.
28. Ghosn M, Kanso C, Kattan J et al. Outcome of cancer patients admittedto the intensive care unit (ICU). J Med Libanais 2002;50:132-37.
29. Hampshire PA, Welch CA, McCrossan LA et al. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: A secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2009;13:Article Number: R137.
30. Hawari FI, Al Najjar TI, Zaru L et al. The effect of implementing highintensity intensive care unit staffing model on outcome of critically ill oncology patients. Crit Care Med 2009;37:1967-71.
31. Hilbert G, Gruson D, Vargas F et al. Noninvasive ventilation inimmunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001;344:481-87.
32. Huaringa AJ, Leyva FJ, Giralt SA et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000;28:1014-17.
33. Kew AK, Couban S, Patrick W et al. Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transpl 2006;12:301-05.
34. Khassawneh BY, White J, P, Anaissie EJ et al. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 2002;121:185-88.
35. Kim S, Kami M, Urahama N et al. Feasibility of Acute Physiology and Chronic Health Evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation. Transplantation 2003;75:566-70.
36. Kress JP, Christenson J, Pohlman AS et al. Outcomes of critically III cancer patients in a university hospital setting. Am J Resp Crit Care Med 1999;160:1957-61.
37. Kroschinsky F, Weise M, Illmer T et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 2002;28:1294-300.
38. Lamia B, Hellot M-, Girault C et al. Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU. Intensive Care Med 2006;32:1560-68.
39. Lecuyer L, Chevret S, Guidet B et al. Case volume and mortality in haematological patients with acute respiratory failure. Eur Resp J 2008; 32:748-54.
40. Letourneau I, Dorval M, Belanger R et al. Acute renal failure in bone marrow transplant patients admitted to the intensive care unit. Nephron 2002;90:408-12.
41. Lim Z, Pagliuca A, Simpson S et al. Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data. Br J Haematol 2007;136:448-50.
42. Massion PB, Dive AM, Doyen C et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002;30:2260-70.
43. Naeem N, Eyzaguirre A, Kern JA et al. Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit. Bone Marrow Transpl 2006;38:733-38.
44. Neumann F, Lobitz O, Fenk R et al. The Sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation. Ann Hematol 2008;87:299-304.
45. Owczuk R, Wujtewicz MA, Sawicka W et al. Patients with haematological malignancies requiring invasive mechanical ventilation: Differences between survivors and non-survivors in intensive care unit. Support Care Cancer 2005;13:332-38.
46. Park HY, Suh GY, Jeon K et al. Outcome and prognostic factors of patients with acute leukemia admitted to the intensive care unit for septic shock. Leukemia Lymphoma 2008;49:1929-34.
47. Pène F, Aubron C, Azoulay E et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: A reappraisal of indications for organ failure supports. J Clin Oncol 2006;24:643-49.
48. Rabbat A, Chaoui D, Montani D et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol 2005;129: 350-57.
49. Rabe C, Mey U, Paashaus M et al. Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation - A retrospective analysis. J Crit Care 2004;19: 29-35.
50. Rabitsch W, Staudinger T, Locker GJ et al. Respiratory failure after stem cell transplantation: Improved outcome with non-I nvasive ventilation. Leukemia Lymphoma 2005;46:1151-57.
51. Regazzoni CJ, Irrazabal C, Luna CM, Poderoso JJ. Cancer patients with septic shock: Mortality predictors and neutropenia. Support Care Cancer 2004;12:833-39.
52. Schellongowski P, Benesch M, Lang T et al. Comparison of three severity scores for critically ill cancer patients. Intensive Care Med 2004;30:430-36.
53. Scott PH, Morgan TJ, Durrant S, Boots RJ. Survival following mechanical ventilation of recipients of bone marrow transplants and peripheral blood stem cell transplants. Anaesth Intensive Care 2002;30:289-94.
54. Shorr AF, Moores LK, Edenfield WJ et al. Mechanical ventilation in hematopoietic stem cell transplantation: Can we effectively predict outcomes? Chest 1999;116:1012-18.
55. Soares M, Salluh JI, Ferreira CG et al. Impact of two different comorbidity measures on the 6-month mortality of critically ill cancer patients. Intensive Care Med 2005;31:408-15.
56. Soares M, Fontes F, Dantas J et al. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care 2004;8:R194-203.
57. Soares M, Salluh JIF. Validation of the SAPS 3 admission prognostic model in patients with cancer in need of intensive care. Intensive Care Med 2006;32:1839-44.
58. Soares M, Salluh JIF, Torres VBL et al. Short- and long-term outcomes of critically III patients with cancer and prolonged ICU length of stay. Chest 2008;134:520-26.
59. Soares M, Salluh JIF, Carvalho MS et al. Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 2006;24:4003-10.
60. Soubani AO, Kseibi E, Bander JJ et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004;126:1604-11.
61. Staudinger T, Stoiser B, Mullner M et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000;28:1322-28.
62. Thakkar SG, Fu AZ, Sweetenham JW et al. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Cancer 2008;112:2233-40.
63. Trinkaus MA, Lapinsky SE, Crump M et al. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant 2009;43: 411-15.
64. Vallot F, Paesmans M, Berghmans T, Sculier JP. Leucopenia is an independent predictor in cancer patients requiring invasive mechanical ventilation: A prognostic factor analysis in a series of 168 patients. Support Care Cancer 2003;11:236-41.
65. Vandijck DM, Benoit DD, Depuydt PO et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008;34: 847-55.
66. Verplancke T, Van Looy S, Benoit D et al. Support vector machine versus logistic regression modelling for prediction of hospital mortality in critically ill patients with haematological malignancies. BMC Medical Informatics Decision Making 2008;8 available from: http://www.biomedcentral.com/1472-6947/8/56. Doi:10.1186/1472-6947-8-56. Accessed 27/10/10
67. Yang TM, Wang PN, Kao KC et al. Outcome of hematopoietic stem cell recipients who were mechanically ventilated and admitted to intensivecare units. J Formos Med Assoc 2007;106:295-301.
68. Cuthbertson BH, Rajalingam Y, Harrison S, McKirdy F. The outcome of haematological malignancy in Scottish intensive care units. JICS 2008; 9: 136-140.
69. Groeger JS, Peter JW, Nierman DM et al. Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol 1999; 17: 991-97.
70. Groeger JS, Glassman J, Nierman DM et al. Probability of mortality of critically ill cancer patients at 72 h of intensive care unit (ICU) management. Support Care Cancer 2003;11:686-95.
71. Taccone FS, Artigas AA, Sprung CL et al. Characteristics and outcomes of cancer patients in European ICUs. Crit Care 2009;13:R15.
72. Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med 1996;125:625-33.
73. Darmon M, Azoulay E. Critical care management of cancer patients: Cause for optimism and need for objectivity. Curr Opin Oncol 2009;21: 318-26.
74. Horner MJ, Ries LAG, Krapcho M et al. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009. 2009; Available at: http://seer.cancer.gov/csr/1975_2006/index.html. Accessed 01/16, 2010.
75. Rohatiner AZS, Slevin ML, Tate T. Medical Oncology. In: Kumar P, Clark M, eds. Clinical Medicine 4th ed.: W.B. Saunders; 1998. p. 415-45.
76. Cancer Research UK. Head and Neck Cancer. 2008; Available at: http://www.cancerhelp.org.uk/type/head-and-neckcancer/ index.htm?script=true. Accessed 22/01/2010.
77. Soares M, Salluh JIF, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs. Crit Care Med 2005;33:520-26.